PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Intensive Care Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.\', \'Department of Anesthesiology and Intensive Care, University of Leipzig, Leipzig, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'Department of Anaesthesiology and Intensive Care, University of Leipzig Medical Center, Leipzig, Germany.\', \'Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/14651858.CD014962
?:hasPublicationType
?:journal
  • The Cochrane database of systematic reviews
is ?:pmid of
?:pmid
?:pmid
  • 34350582
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Remdesivir for the treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34350582>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34350582>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all